Industry News

CDC Boss Bemoans Liberia - 'Worst Ever Ebola Outbreak'
Pfizer's Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN
Canada's Lawson Health Research Institute Investigates Groundbreaking New Technology to Monitor Cerebral Blood Flow in Cardiac Surgery Patients
VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension
Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO
Conatus Pharmaceuticals Initiates Phase 2 Trial In Patients With Liver Cirrhosis And Separate Open Label Phase 2 Trial In Cirrhosis Patients With Portal Hypertension
Salix Submits Response to XIFAXAN 550mg Complete Response Letter Regarding Repeat Treatment for Irritable Bowel Syndrome with Diarrhea
Zogenix Reports Zohydro ER Shows Sustained 12-Hour Pain Relief
Synexus to Acquire Helderberg Clinical Trials Centre
Ligand Pharmaceuticals: FDA to OK GlaxoSmithKline Promacta/Revolade
Jason Yang and Wendy Yan to Join BeiGene
United States : NATCO Pharmas partner Mylan applies for Copaxone generic
Local company preps for growth with headquarter building plans
Pfizer Investigational Vaccine for Clostridium Difficile Receives Fast Track Designation
NIH to Launch Human Safety Study of Ebola Vaccine Candidate
Local company preps for growth with headquarter building plans
ISPE Releases First Look at its Plan to Prevent Drug Shortages
CDC Boss Bemoans Liberia - 'Worst Ever Ebola Outbreak'
Amneal Pharmaceuticals Announces Four New Generics Amneal Pharmaceuticals
New type 2 diabetes treatment Jardiance (empagliflozin) tablets for adults now available in U.S. pharmacies New JARDIANCE Simple Savings program currently offered in doctors' offices and online
Fresenius Kabi Receives FDA approval for Kabiven and Perikabiven
Roche to buy US biotech firm InterMune for $8.3billion
Janssen Affiliate Cilag GmbH International Acquires Covagen AG Clinical Candidate COVA 322 and FynomAb Technology Platform Further Strengthen Immunology Portfolio and Capabilities